Oxford Ledge
Search
Medtronic plc (NYSE: MDT) is a $118.0B medical - devices company trading at $92.18 — 24.7× trailing earnings, yielding 3.06%. Figures from SEC EDGAR and market feeds; updated 2026-09-03 12:08 UTC.
The company faces operational risks related to data security, cybersecurity breaches, and the use of artificial intelligence systems in its business, which could result in regulatory sanctions, litigation, reputational damage, and financial losses. The company operates internationally and is subject to anti-corruption laws including the Foreign Corrupt Practices Act and similar regulations in other jurisdictions, with particular exposure in countries with government-administered healthcare systems. The company's international operations also subject it to U.S.
Summarized from Medtronic plc’s SEC filings · Read the filing ↗
| Quote | |
| Price | $92.18 |
| Market cap | $118.0B |
| 52-week range | $73.31 – $95.41 |
| Valuation | |
| P/E (TTM) | 24.71× |
| EV/EBITDA | 12.50× |
| EPS (TTM) | $3.73 |
| Dividend yield | 3.06% |
| Price/book | 2.39× |
| Return on equity | 9.71% |
| Debt/equity | 0.04 |
| Returns | |
| 52-week return | +25.7% |
Medtronic plc (MDT) reported 2 operating metrics for Q4 2026 in its SEC earnings exhibit filed 2026-06-03.
Most recent reported period: Q4 2026, filed 2026-06-03.
| Segment revenue | $9.81B |
See how MDT compares across the industry →
Oxford Ledge Signal — extracted from the issuer’s own SEC earnings exhibit and normalized by Oxford Ledge; as reported by the issuer per regulatory convention, not re-audited by us. Source: SEC EDGAR ↗
| Revenue growth | +9.9% |
Every figure in this table is a CHANGE the issuer reported for the period, not a level. Growth rates and levels never share a column or a table -- a change read as a level is a different number entirely.
Oxford Ledge Signal — extracted from the issuer’s own SEC earnings exhibit and normalized by Oxford Ledge; as reported by the issuer per regulatory convention, not re-audited by us. Source: SEC EDGAR ↗
The company faces operational risks related to data security, cybersecurity breaches, and the use of artificial intelligence systems in its business, which could result in regulatory sanctions, litigation, reputational damage, and financial losses.
MDT trades at $92.18, 24.71× trailing earnings, 12.50× EV/EBITDA, as of 2026-09-03. It carries a 3.06% dividend yield.
Medtronic plc's most recent SEC filing on record is a DEF 14A filed 2026-08-17. All filings link to their SEC EDGAR originals above.
SEC EDGAR filings and public market data feeds, fetched 2026-09-03 12:08 UTC. This page is also available as JSON at /api/data?ticker=MDT and is emitted with FAQPage structured data for machine reading.
Charts, 10-year financials, peer comparison, screening and portfolio tracking for MDT and 5,000+ tickers.
Create a free account — keep MDTGET /api/data?ticker=MDT
This page as JSON via rel="alternate" · REST API docs · MCP server (59 tools) · llms.txt